Daily treatment of patients with IgA nephropathy with an oral glucocorticoid, methylprednisolone, led to significant reductions in the rate of […]
New DAPA-CKD Analysis Hints at Dapagliflozin for IgA Nephropathy
Treatment with the sodium-glucose cotransporter-2 (SGLT2) inhibitor dapagliflozin (Farxiga) was safe and effective for slowing progression of chronic kidney disease […]
Missed Visits During Pandemic Cause ‘Detrimental Ripple Effects’
More than one third of adults aged 18-64 years in the United States delayed or went without medical care because […]